Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.
Dyadic caregiver-child interactions are commonly used to examine children’s language learning environments.
Individuals with Down syndrome have a 90% lifetime risk of developing Alzheimer’s disease.
Down syndrome, a neurodevelopmental condition caused by a triplicated 21st chromosome, often presents with co-occurring developmental conditions such as autism. But diagnosing autism in someone with Down syndrome can be difficult as they have overlapping symptoms.
The METabolic Health, Lifestyle, and Risk of Co-Occurring Health Conditions in Down Syndrome (MET-DS) study is part of the NIH INCLUDE Project (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndrome) and its Collaboration for Down Syndrome Progress (CDP) Program—national initiatives working to improve the health and quality of life of people with …
A new Waisman study found that adverse childhood experiences (ACEs)—such as abuse, neglect, or exposure to household challenges—can have lasting effects on adults with Down syndrome, including their mental health and ability to cope with life changes. While ACES are known to impact the general population, this research is among the first to show similar—and in some cases heightened—effects in individuals with Down syndrome.
Basal forebrain cholinergic neurons (BFCNs) are integral to learning, attention, and memory, and are prone to degeneration in Down syndrome (DS), Alzheimer’s disease, and other neurodegenerative diseases.
Individuals with Down syndrome (DS) have a higher incidence of hearing loss (HL) compared with their peers without developmental disabilities.
Mean physical and behavioral depressive symptoms on the Reiss Screen of Maladaptive Behavior (RSMB) across four data collection cycles in sample of 262 adults with Down syndrome. Blue line is for those with low PET amyloid and green line for those with elevated PET amyloid.
Researchers at the Waisman Center are included in a recently launched a new long-term study to observe and track health data of people with Down syndrome from birth to adulthood
Three Waisman Center investigators and affiliates were awarded an internal grant to support Down syndrome research in its early stages. The funds were made possible through the Ann Dewey Down Syndrome Catalyst Fund at the Waisman Center.
